United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 250 mg - cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae and streptococcus pyogenes. cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae , haemophilus influenzae , staphylococcus aureus , streptococcus pyogenes , and moraxella catarrhalis. cephalexin is indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus and streptococcus pyogenes . cephalexin is indicated for the treatment of bone infections caused by susceptible isolates of staphylococcus aureus and proteus mirabilis. cephalexin is indicated for the treatment of genitourinary tract infections, including acute prostatitis, caused by susceptible isolates of escherichia coli , proteus mirabilis , and klebsiella pneumoniae . to reduce the development of drug-resistant bacteria and maintain the effectiveness of cep

United States - English - NLM (National Library of Medicine)

ranbaxy pharmaceuticals inc. - cephalexin (unii: obn7uds42y) (cephalexin - unii:obn7uds42y) - 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules and cephalexin for oral suspension and other antibacterial drugs, cephalexin capsules and cephalexin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cephalexin is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: respiratory tract infections caused by s. pneumoniae and s. pyogenes (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in the eradicati

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 75.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | including b-lactamase producin | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | salmonellosis | staphylococcus spp. | tonsillitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 300.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | including b-lactamase producin | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | salmonellosis | staphylococcus spp. | tonsillitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 600.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | including b-lactamase producin | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | salmonellosis | staphylococcus spp. | tonsillitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 600.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | including b-lactamase producin | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | salmonellosis | staphylococcus spp. | tonsillitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 300.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | acute respiratory infections | bronchiseptica | bronchitis | escherichia coli | group d streptococcus | including b-lactamase producin | klebsiella spp. | pharyngitis | pneumonia | proteus spp. | pseudomonas aeruginosa | salmonellosis | staphylococcus spp. | tonsillitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - cephalexin as cephalexin monohydrate - oral tablet - cephalexin as cephalexin monohydrate antibiotic active 75.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotic - anti-infective | enterobacter spp. | escherichia coli (e. coli) | infections of soft cutaneous tissue | infections of the digestive tract | infections of the respiratory tract | infections of the urinary tracts | klebsiella spp. | osteomyelitis | proteus spp. | salmonella | shigella spp. | staphylococcus aureus | abrasions | abscesses | acute respiratory infections | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | bronchiseptica | bronchitis | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | escherichia coli | feed efficiency | fungal infections | girth galls | group d streptococcus | including b-lactamase producin | infections | inflammed pads | itching | keratolytic | klebsiella spp. | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pharyngit

United States - English - NLM (National Library of Medicine)

virbac ah, inc - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin 150 mg - rilexine chewable tablets are contraindicated in dogs with a known allergy to cephalexin or to the β-lactam (any of the penicillins or cephalosporins) group of antibiotics. 

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cefalexin monohydrate, quantity: 525.76 mg (equivalent: cefalexin, qty 500 mg) - capsule, hard - excipient ingredients: magnesium stearate; microcrystalline cellulose; gelatin; purified water; titanium dioxide - treatment of the following infections when caused by susceptible strains of the designated microorganisms. respiratory tract infections. caused by s. pneumoniae and group a beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). bacterial sinusitis. caused by streptococci, s. pneumoniae and s. aureus (methicillin sensitive only). otitis media. due to s. pneumoniae, staphylococci. skin and skin structure infections. caused by staphylococci and/or streptococci. genitourinary tract infections, including acute prostatitis. caused by e. coli, p. mirabilis, and klebsiella sp. the effectiveness of cephalexin in the treatment of bacterial infections of the brain and s